1. Home
  2. NHI vs TMDX Comparison

NHI vs TMDX Comparison

Compare NHI & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NHI
  • TMDX
  • Stock Information
  • Founded
  • NHI 1991
  • TMDX 1998
  • Country
  • NHI United States
  • TMDX United States
  • Employees
  • NHI N/A
  • TMDX N/A
  • Industry
  • NHI Real Estate Investment Trusts
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NHI Real Estate
  • TMDX Health Care
  • Exchange
  • NHI Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • NHI 3.7B
  • TMDX 4.0B
  • IPO Year
  • NHI 1991
  • TMDX 2019
  • Fundamental
  • Price
  • NHI $76.56
  • TMDX $120.05
  • Analyst Decision
  • NHI Buy
  • TMDX Buy
  • Analyst Count
  • NHI 4
  • TMDX 11
  • Target Price
  • NHI $82.75
  • TMDX $130.73
  • AVG Volume (30 Days)
  • NHI 187.5K
  • TMDX 1.0M
  • Earning Date
  • NHI 11-06-2025
  • TMDX 10-29-2025
  • Dividend Yield
  • NHI 4.83%
  • TMDX N/A
  • EPS Growth
  • NHI 8.88
  • TMDX 170.70
  • EPS
  • NHI 3.17
  • TMDX 2.54
  • Revenue
  • NHI $357,572,000.00
  • TMDX $566,354,000.00
  • Revenue This Year
  • NHI $4.68
  • TMDX $38.84
  • Revenue Next Year
  • NHI $10.60
  • TMDX $20.46
  • P/E Ratio
  • NHI $24.03
  • TMDX $47.00
  • Revenue Growth
  • NHI 8.40
  • TMDX 41.20
  • 52 Week Low
  • NHI $65.13
  • TMDX $55.00
  • 52 Week High
  • NHI $82.32
  • TMDX $145.50
  • Technical
  • Relative Strength Index (RSI)
  • NHI 51.80
  • TMDX 47.25
  • Support Level
  • NHI $74.87
  • TMDX $115.21
  • Resistance Level
  • NHI $77.88
  • TMDX $125.57
  • Average True Range (ATR)
  • NHI 1.79
  • TMDX 7.44
  • MACD
  • NHI 0.25
  • TMDX -1.15
  • Stochastic Oscillator
  • NHI 65.08
  • TMDX 20.25

About NHI National Health Investors Inc.

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: